Research of effectiveness of parvulyte gel® in dogs with parvoviral enteritis

In this study, it was aimed to demonstrate the efficacy of Parvulyte® in dogs with parvoviral enteritis. The animal material of the study consisted of 14 dogs that were diagnosed with parvoviral enteritis as a result of clinical examination and immunochromatographic rapid test kits brought to Afyon Kocatepe University Veterinary Health Application and Research Center Internal Diseases Clinic and private veterinary clinics in Izmir. After the diagnosis of parvoviral enteritis, dogs were treated with fluid therapy+vitamin-mineral-electrolyte-amino acid supplementation+pantoprazole+cefazolin sodium+maropitant citrate (Group I, n=7) and fluid therapy+vitamin-mineral-electrolyte-amino acid supplementation+pantoprazole +cefazolin sodium + maropitant citrate+Parvulyte® (Group II, n=7). Both groups were treated for 7 days. It was observed that the dogs in Group II had an increase in the lymphocyte count, a faster increase in antibody titers, and a faster clinical recovery compared to the stool scoring table created. As a result, it was concluded that Parvulyte® accelerated the clinical recovery and shortened the hospitalization time in dogs with parvoviral enteritis.